Direct beauty seller Nu Skin Enterprises’ (NUS) stock price rose fourfold in 2013 from previous year’s lows due to unfounded fears of being associated with Herbalife Ltd. (HLF), says Andrew Absler, a Senior Research Analyst at Lombardia Capital Partners, LLC, and Portfolio Manager for the Small Cap Value Portfolio.
“The fears proved unfounded, and the stock experienced both multiple expansion and tremendous earnings growth. Today the stock is in excess of $130, which is approximately a fourfold increase from its lows,” Absler explained.
FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.
Absler says about 10% of Nu Skin sales for its beauty and personal care products come from North America, and he says Asian markets currently provide significant growth for the direct seller.
Absler commented that Nu Skin’s stock performance in 2013 made it Small Cap Value Portfolio’s best performer. He added that others were not as keen on the stock during the controversy, but Lombardia did not follow the crowd. “Steve Malcolm is the primary analyst on the stock, and to his credit he stuck with the name during the controversy and pushed us to buy more when the stock was weak,” Absler said.
Nu Skin Enterprises, Inc. (NUS) Prepped for Growth with Innovative Health Care Products
June 17, 2014
CEO Watch List – Sir Stuart Rose, Marks and Spencer, Update 1
June 25, 2008
Recommended Reading – Sir Stuart Rose reshuffles his team at Marks & Spencer, Times Online
May 20, 2009
Railroads See Significant Falloff says Seidl of Dahlman Rose
June 23, 2009
Insight Enterprises Inc. Appoints New CEO To Fill Vacancy
December 21, 2009
